# Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan

> **NCT00249977** · PHASE1 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 21 (actual)

## Conditions studied

- Solid Tumors
- Cancer

## Interventions

- **DRUG:** Capecitabine in Combination with Cisplatin and Irinotecan

## Key facts

- **NCT ID:** NCT00249977
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2007-08
- **Final completion:** 2009-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2010-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249977, "Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00249977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*